Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication
1
x
$
30.00
Charles B. Nemeroff, MD, PhD: The Role of GABA in the Pathophysiology and Treatment of Anxiety Disorders
1
x
$
30.00
Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder
1
x
$
30.00
New Developments in the Neurobiological Basis of Anxiety Disorders
1
x
$
30.00
Impact of a Student Pharmacist Driven Medication Reconciliation and Antidepressant Treatment History Project at a Depression Clinic: A Pilot Study
1
x
$
30.00
Long Acting Risperidone in an Adolescent - Mustafa Deniz Tutkunkardas
1
x
$
30.00
Pharmacokinetics, Drug Interactions, and Tolerability of Valproate
1
x
$
30.00
VOL 2 No. 2 Full Issue - February 2000
1
x
$
20.00
Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study
1
x
$
30.00
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
1
x
$
30.00
John P. Houston - Early Symptom Change Prediction of Remission in Depression Treatment
1
x
$
30.00
View Cart
Checkout
Home
duloxetine
“John P. Houston – Early Symptom Change Prediction of Remission in Depression Treatment” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Takotsubo Cardiomyopathy Related to Duloxetine-Atomoxetine Combination in an Adolescent with ADHD and Comorbid GAD
$
30.00
Add to cart
Details
Impact of Polymorphism of CYP2D6 on Equilibrium Concentration of Duloxetine in Patients Suffering from Major Depressive Disorder
$
30.00
Add to cart
Details
Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial
$
30.00
Add to cart
Details
Charles B. Nemeroff, MD, PhD: Duloxetine for the Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
John P. Houston – Early Symptom Change Prediction of Remission in Depression Treatment
$
30.00
Add to cart
Details
Assessment of Anxiety in Clinical Trials with Depressed Patients
$
30.00
Add to cart
Details
Page load link
Go to Top
